Device-Related Thrombus

SAN FRANCISCO — One-year data from the SWISS-APERO study show similar clinical outcomes and rates of patent left atrial appendages for patients undergoing LAA closure with either the Amulet or Watchman FLX devices, a speaker reported.

A next-generation device for closure of the left atrial appendage to prevent thrombus embolization in patients with nonvalvular atrial fibrillation met its safety and efficacy goals, according to the results of the PINNACLE FLX study.